ESIFLO 250MCG TRANSCAP 30'S

Content Reviewed By:

Written By:

• ESIFLO 250MCG TRANSCAP 30'S is a combination medication containing fluticasone and formoterol, used to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). Fluticasone is a corticosteroid that reduces inflammation in the airways, while formoterol is a long-acting beta-agonist (LABA) that relaxes the muscles in the airways, improving airflow.
• One of the primary benefits of ESIFLO 250MCG TRANSCAP is its effectiveness in controlling asthma symptoms. Regular use helps to reduce the frequency and severity of asthma attacks, including wheezing, shortness of breath, chest tightness, and coughing. By addressing both inflammation and bronchoconstriction, ESIFLO provides comprehensive asthma management.
• In COPD, ESIFLO 250MCG TRANSCAP helps to alleviate symptoms such as chronic cough, excessive mucus production, and difficulty breathing. It improves lung function, making it easier for individuals with COPD to perform daily activities and enhancing their overall quality of life. The bronchodilatory effect of formoterol opens up the airways, while fluticasone reduces inflammation, leading to better respiratory function.
• ESIFLO 250MCG TRANSCAP offers a convenient and consistent way to manage respiratory conditions. The transcap delivery system ensures accurate dosing and efficient drug delivery directly to the lungs. This ease of use promotes adherence to the prescribed treatment regimen, which is essential for achieving optimal therapeutic outcomes.
• Using ESIFLO 250MCG TRANSCAP can lead to fewer exacerbations or flare-ups of asthma and COPD. By maintaining consistent control over airway inflammation and bronchoconstriction, the medication reduces the risk of sudden worsening of symptoms that may require hospitalization or emergency medical care. This proactive approach to disease management improves long-term respiratory health.
• ESIFLO 250MCG TRANSCAP enhances exercise tolerance in individuals with asthma and COPD. By improving airflow and reducing breathlessness, the medication enables patients to engage in physical activities with greater ease and comfort. This increased exercise capacity contributes to improved physical fitness and overall well-being.
• The anti-inflammatory properties of fluticasone in ESIFLO 250MCG TRANSCAP help to protect the airways from damage caused by chronic inflammation. This preventative effect can slow the progression of airway remodeling in asthma and COPD, preserving lung function over time.
• ESIFLO 250MCG TRANSCAP can reduce the need for rescue medications, such as short-acting beta-agonists (SABAs), in both asthma and COPD. By providing long-lasting control of symptoms, the medication decreases reliance on quick-relief inhalers, which can have side effects when used frequently.
• By effectively managing respiratory symptoms, ESIFLO 250MCG TRANSCAP contributes to improved sleep quality. Reduced coughing and breathlessness, particularly at night, lead to more restful sleep and improved daytime functioning.
• ESIFLO 250MCG TRANSCAP, through its dual-action mechanism, provides a synergistic effect, meaning the combination of fluticasone and formoterol is more effective than either medication used alone. This combined approach ensures better symptom control and improved respiratory outcomes.
• The consistent use of ESIFLO 250MCG TRANSCAP aids in maintaining stable lung function, preventing further decline in respiratory health, especially important in progressive conditions such as COPD. This stability allows patients to lead more active and fulfilling lives with fewer limitations imposed by their respiratory condition.

• ESIFLO 250MCG TRANSCAP is designed for inhalation using a suitable inhaler device. It's crucial to use it correctly to ensure the medication reaches your lungs effectively. Here's a step-by-step guide:
• 1. **Preparation:** Before each use, remove the cap of the inhaler and check the mouthpiece for any foreign objects. Ensure the inhaler is clean and dry.
• 2. **Loading the Capsule:** Open the inhaler device and carefully place one ESIFLO 250MCG TRANSCAP into the designated chamber. Close the device tightly.
• 3. **Priming the Capsule:** Most inhaler devices require you to prime the capsule by pressing buttons or twisting the device to pierce the capsule. This releases the medication for inhalation. Refer to your inhaler's instruction manual for the exact priming procedure.
• 4. **Exhalation:** Breathe out fully, away from the inhaler. Empty your lungs as much as possible.
• 5. **Inhalation:** Place the mouthpiece of the inhaler into your mouth, creating a tight seal with your lips. Tilt your head slightly back. Breathe in deeply and forcefully through your mouth. You should hear the capsule spinning inside the inhaler, indicating that the medication is being released.
• 6. **Breath-Holding:** After inhaling fully, remove the inhaler from your mouth and hold your breath for about 10 seconds, or as long as comfortable. This allows the medication to settle in your lungs.
• 7. **Exhalation:** Breathe out slowly through your nose.
• 8. **Repeat if Necessary:** If your doctor has prescribed more than one inhalation, repeat steps 4-7.
• 9. **Post-Inhalation:** After using the inhaler, rinse your mouth with water and spit it out. This helps prevent thrush (a fungal infection) in the mouth.
• 10. **Cleaning:** Clean your inhaler device regularly according to the manufacturer's instructions. This helps prevent the buildup of medication and ensures proper functioning.
• **Important Considerations:**
• - Always use ESIFLO 250MCG TRANSCAP as prescribed by your doctor. Do not exceed the recommended dose.
• - If you experience any difficulty breathing or other side effects, seek medical attention immediately.
• - Store ESIFLO 250MCG TRANSCAP in a cool, dry place, away from direct sunlight and moisture.
• - Keep out of reach of children.
• - Do not swallow the capsules; they are intended for inhalation only.
• - If you have any questions or concerns about using ESIFLO 250MCG TRANSCAP, consult your doctor or pharmacist.